medigraphic.com
ISSN 1527-3172 (Electronic)

2012, Number 3

<< Back Next >>

MEDICC Review 2012; 14 (3)

Continuous venovenous hemodiafiltration in patients with multiple organ dysfunction syndrome in an Intensive Care Unit

Abdo AA, Castellanos R, Rocha M, Hernández E, Leal G, Suárez J, Gutiérrez JA, Gómez F, Cueto A

Language: English
References: 36
Page: 26-30
PDF size: 158.46 Kb.


ABSTRACT

Introduction: Continuous venovenous hemodiafiltration, generally used in patients with acute renal failure, enables elimination of humoral mediators of systemic inflammatory response and sepsis from blood. This effect should improve treatment results in patients with multiple organ dysfunction, but evidence of improved survival is insufficient.
Objetive: Describe the effect of continuous venovenous hemodiaflitration on patients with multiple organ dysfunction syndrome in terms of systemic and brain hemodynamics, oxygenation, metabolism and status on ICU separation.
Methods: An observational case series was done of 18 patients (11 men and 7 women) aged 24–78 years with multiple organ dysfunction syndrome treated with continuous venovenous hemodiafiltration in the Medical-Surgical Research Center's ICU in Havana. General, systemic and brain hemodynamic, oxygenation and metabolic variables were assessed immediately before and 12 hours after starting the procedure; vital status on separation from intensive care was recorded. For analysis, patients were grouped by whether cause of multiple organ dysfunction syndrome was septic or nonseptic. Variable means before and after treatment were compared using the Wilcoxon matched pairs test. Standardized mortality ratios were calculated for both groups, with survival efficacy defined by a ratio of ‹ 0.9.
Results: After 12 hours continuous venovenous hemodiafitration, the septic group showed clinical improvement, with statistically significant improvement in all variables except mean arterial pressure and brain hemodynamics. Survival to discharge from ICU was 64%, with a standardized mortality ratio of 0.66. In the nonseptic group, survival was 0% and ratio was 2.13; temperature was the only variable found to improve significantly.
Conclusions: Continuous venovenous hemodiafltration improved clinical parameters and survival in patients with multiple organ dysfunction of septic origin. Further studies are needed with larger numbers of patients to corroborate these results.


REFERENCES

  1. Kramer P, Wigger W, Rieger J, Matthaei D, Scheler F. [Arteriovenous hemofi ltration: A new and simple method for treatment of overhydratated patients resistant to diuretics]. Klin Wochenschr. 1977 Nov 15;55(22):1121–2. German.

  2. Blankestijn PJ, Ledebo I, Canaud B. Hemodiafi ltration: clinical evidence and remaining questions. Kidney Int. 2010 Apr;77(7):581–7.

  3. Saito A. Current progress in blood purifi cation methods used in critical care medicine. Contrib Nephrol. 2010;166:100–11.

  4. Dunham CM. Clinical impact of continuous renal replacement therapy on multiple organ failure. World J Surg. 2001 May;25(5):669–76.

  5. O`Brien JM Jr, Lu B, Ali NA, Levine DA, Aberegg SK, Lemeshow S. Insurance type and sepsisassociated hospitalizations and sepsis-associated mortality among US adults: a retrospective cohort study. Crit Care. 2011;15(3):R130.

  6. Vincent JL, Nelson DR, Williams MD. Is worsening multiple organ failure the cause of death in patients with severe sepsis? Crit Care Med. 2011 May;39(5):1050–5.

  7. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic infl ammatory response. Curr Opin Crit Care. 2011 Apr;17(2):153–9.

  8. Cosentino F, Paganini E, Lockrem J, Stoller J, Wiedemann H. Continuous arteriovenous hemofi ltration in the adult respiratory distress syndrome: a randomized trial. Contrib. Nephrol. 1991;93:94–7.

  9. Garzia F, Todor R, Scalea T. Continuous arteriovenous hemofi ltration countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma. 1991 Sep;31(9):1277–84.

  10. Inoue K, Watanabe T, Maruoka N, Kuroki Y, Takahashi H, Yoshiba M. Japanese-style intensive medical care improves prognosis for acute liver failure and the perioperative management of liver transplantation. Transplant Proc. 2010 Dec;42(10):4109–12.

  11. Blinzler L, Hausser J, Bödeker H, Zaune U, Martin E, Gebhardt C. Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofi ltration. Contrib Nephrol. 1991;93:234–6.

  12. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003773.

  13. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al. Hemodiafe Study Group. Continuous venovenous haemodiafi ltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006 Jul 29;368(9533):379–85.

  14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: defi nitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992 Jun;20(6):864–74.

  15. Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008 Apr;23(4):1203–10.

  16. Sundaram V, Shaikh OS. Acute liver failure: current practice and recent advances. Gastroenterol Clin North Am. 2011 Sep;40(3):523–39.

  17. Villar J, Blanco J, Kacmarek RM. Acute respiratory distress syndrome defi nition: do we need a change? Curr Opin Crit Care. 2011 Feb;17(1):13–7.

  18. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classifi cation system. Crit Care Med. 1985 Oct;13(10):818–29.

  19. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis- related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707–10.

  20. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, Boer W, De Waele E, et al. Septic AKI in ICU patients. Diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care. 2011 Aug 9;1(1):32.

  21. McGee WT, Headley JM, editors. Quick Guide to Cardiopulmonary Care [Internet]. 2nd ed. California: Edwards Lifesciences; [date unknown] [cited 2012 Mar 30]. Available from: http://ht.edwards .com/sci/edwards/sitecollectionimages/products/ mininvasive/ewquickguide2ed.pdf

  22. White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive Care Med. 2006 Jul;32(7):981–94.

  23. Abizanda R, Reig R, Ferrándiz A, Mas S. El cuadro de mando de la gestión clínica en Medicina Intensiva [Internet]. REMI. 2009 Apr [cited: 2011 Feb 20];9(4):A99. Available from: http://remi.uninet. edu/2009/04/REMIA099i.html. Spanish.

  24. Sirvent JM, Vallés M, Navas E, Calabia J, Ortiz P, Bonet A. [Outcome of critically ill patients with acute renal failure and multiple organ failure treated with continuous venovenous haemodiafi ltration]. Med Intensiva. 2010 Mar;34(2):95–101. Spanish.

  25. Page B, Vieillard-Baron A, Chergui K, Peyrouset O, Rabiller A, Beauchet A, et al. Early venovenous haemodiafi ltration for sepsis-related multiple organ failure. Crit Care. 2005;9(6):R755–63.

  26. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, et al. Prospective evaluation of short-term, high-volume isovolemic hemofi ltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med. 2000 Nov;28(11):3581–7.

  27. Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, et al. Continuous hemodiafi ltration with PMMA Hemofi lter in the treatment of patients with septic shock. Mol Med. 2008 May–Jun;14(5–6):257–63.

  28. Arata S, Tanaka K, Takayama K, Moriwaki Y, Suzuki N, Sugiyama M, et al. Treatment of hepatic encephalopathy by on-line hemodiafi ltration: a case series study. BMC Emerg Med. 2010 May 21;10:10.

  29. Yokoi T, Oda S, Shiga H, Matsuda K, Sadahiro T, Nakamura M, et al. Effi cacy of high-fl ow dialysate continuous hemodiafi ltration in the treatment of fulminant hepatic failure. Transfus Apher Sci. 2009 Feb;40(1):61–70.

  30. Abdo A, López O, Fernández A, Santos J, Castillo J, Castellanos R, et al. Transcranial Doppler sonography in fulminant hepatic failure. Transplant Proc. 2003 Aug;35(5):1859–60.

  31. Matsuda K, Moriguchi T, Oda S, Hirasawa H. Effi cacy of continuous hemodiafi ltration with a cytokine-adsorbing hemofi lter in the treatment of acute respiratory distress syndrome. Contrib Nephrol. 2010;166:83–92.

  32. Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med. 2010 Feb;36(2):210–3.

  33. Kira S, Daa T, Kashima K, Mori M, Noguchi T, Yokoyama S. Mild hypothermia reduces expression of intercellular adhesion molecule- 1(ICAM-1) and the accumulation of neutrophils after acid-induced lung injury in the rat. Acta Anaesthesiol Scand. 2005 Mar;49(3):351–9.

  34. Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med. 2009 Jul;37(7 Suppl):S258–64.

  35. Soni SS, Nagarik AP, Adikey GK, Raman A. Using continuous renal replacement therapy to manage patients of shock and acute renal failure. J Emerg Trauma Shock. 2009 Jan;2(1):19–22.

  36. den Hoedt CH, Mazairac AH, van den Dorpel MA, Grooteman MP, Blankestijn PJ. Effect of hemodiafi ltration on mortality, infl ammation and quality of life. Contrib Nephrol. 2011;168:39–52.




2020     |     www.medigraphic.com